Vertex Pharmaceuticals Inc. buy Bank of America Co.
Start price
31.03.25
/
50%
€456.50
Target price
31.03.26
€523.00
Performance (%)
-4.95%
Price
07:54
€433.90
Summary
This prediction is currently active. With a performance of -4.95%, the BUY prediction for Vertex Pharmaceuticals Inc. by Bank_of_America_Co_ is down slightly. This prediction currently runs until 31.03.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | 4.802% | 4.802% |
| iShares Core DAX® | -0.975% | -4.716% |
| iShares Nasdaq 100 | 1.163% | 1.881% |
| iShares Nikkei 225® | -1.593% | -5.385% |
| iShares S&P 500 | -0.278% | 0.327% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Bank of America Co. from $555.00 to $567.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€432.95
10.03.26
10.03.26
€514.40
10.03.27
10.03.27
-1.20%
07:54
07:54
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€377.00
19.12.24
19.12.24
€503.63
19.12.25
19.12.25
3.34%
20.12.25
20.12.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€444.75
14.10.24
14.10.24
€496.10
14.10.25
14.10.25
-20.33%
15.10.25
15.10.25